BioMarin Pharmaceutical Inc. (B1MR34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 144.05 |
|---|---|
| 52-week range | 123.51 – 174.41 |
| Return, 1 month / 3 months | −13.1% / −3.6% |
| Return, 1 year / 3 years | +0.2% / −35.2% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -28.2% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BioMarin Pharmaceutical is a biotechnology company that develops and markets medicines for rare genetic disorders. Its treatments address conditions such as phenylketonuria, certain mucopolysaccharidoses and achondroplasia, and it also produces enzyme replacement therapies. The company serves patients and specialist physicians through hospitals and treatment centres, and it is based in San Rafael, California, in the United States.
BioMarin Pharmaceutical Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code B1MR34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BioMarin Pharmaceutical Inc. (B1MR34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 144.05 on 15 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 752 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.2% and over the last three months it fell 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.9% | ||
| From 52-week high | -16.2% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.6% | ||
| 6-month return | 3.3% | ||
| 12-month return, skipping the last month | 15.3% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.2% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 63.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | −13.1% |
| 3 months | −3.6% |
| 6 months | +3.3% |
| 1 year | +0.2% |
| 3 years | −35.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 161.46 / 151.43 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.55 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.